financetom
Business
financetom
/
Business
/
This startup can help you absorb a financial shock without getting into debt
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
This startup can help you absorb a financial shock without getting into debt
Oct 13, 2020 11:10 AM

Imagine a startup that will help you absorb a financial shock or an unexpected expense, or allow you to withdraw your salary in advance, without getting into debt.

A fintech startup called ‘Valyu Ai' focuses on advanced salary solutions and has tie-ups with large payroll processing companies. The company's model essentially allows employees to withdraw a percentage of their unpaid but accrued earnings straight into their salary account whenever they need it.

These advances are given to employees within minutes while surpassing any cumbersome paperwork, CIBIL score check or financial background check.

To find out more about this venture, CNBC-TV18 spoke to the Co-Founder and Head of Product and Strategy Rashoo Kame.

Also, find out more about India's first gaming console called 'Raji: An Ancient Epic' developed by Nodding Head Games.

For more, watch the video.

First Published:Oct 13, 2020 8:10 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Genprex Completes Phase 1 Dose Escalation in Trial of Reqorsa Gene Therapy to Treat Lung Cancer
Genprex Completes Phase 1 Dose Escalation in Trial of Reqorsa Gene Therapy to Treat Lung Cancer
Dec 16, 2024
09:58 AM EST, 12/16/2024 (MT Newswires) -- Genprex ( GNPX ) said Monday that it has completed the phase 1 dose escalation portion of a trial of Reqorsa gene therapy in combination with Tecentriq to treat extensive stage small cell lung cancer. The company also said the Safety Review Committee has approved initiating the phase 2 expansion part of the...
Ford's Joint Venture With SK On Obtains $9.63 Billion US Energy Department Loan
Ford's Joint Venture With SK On Obtains $9.63 Billion US Energy Department Loan
Dec 16, 2024
09:52 AM EST, 12/16/2024 (MT Newswires) -- Ford Motor's ( F ) BlueOval SK joint venture with SK On has obtained a direct loan of up to $9.63 billion loan from the US Department of Energy to fund the construction of three battery manufacturing plants, the DOE said Monday. The facilities, located in Tennessee and Kentucky, are designed for over...
Novo's Ozempic faces scrutiny over potential link to rare eye disease
Novo's Ozempic faces scrutiny over potential link to rare eye disease
Dec 16, 2024
COPENHAGEN, Dec 16 (Reuters) - Danish health authorities said on Monday they would ask the European Union's drug regulator to review the findings of two Danish studies linking Novo Nordisk's popular diabetes drug Ozempic to a rare sight-threatening eye condition. The two studies conducted by University of Southern Denmark (SDU) found that Ozempic more than doubles the risk of NAION,...
MAIA Biotechnology's THIO Gets US FDA Rare Pediatric Disease Designation to Treat Pediatric High-Grade Gliomas
MAIA Biotechnology's THIO Gets US FDA Rare Pediatric Disease Designation to Treat Pediatric High-Grade Gliomas
Dec 16, 2024
09:46 AM EST, 12/16/2024 (MT Newswires) -- MAIA Biotechnology ( MAIA ) said Monday its investigational telomere-targeting agent THIO received a rare pediatric disease designation from the Food and Drug Administration to treat pediatric-type diffuse high-grade gliomas. The company partnered with Only Orphans Cote for THIO's designation request, it added. MAIA said that THIO is currently in clinical development for...
Copyright 2023-2026 - www.financetom.com All Rights Reserved